Trulieve Cannabis Corp. Receives Initial DEA Registrations for Medical Marijuana Dispensaries

Trulieve Cannabis Corp. received initial U.S. Drug Enforcement Administration registrations for its medical marijuana dispensaries, after applying in April 2026. The registrations follow the federal rescheduling of medical cannabis to Schedule III and the DEA’s launch of a process for qualifying state-licensed businesses. CEO Kim Rivers said the change could support clinical research and create a more equitable operating environment; the article reports no financial figures or stock-price impact.